Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Data Regulatory News (MAST)

  • There is currently no data for MAST

MED Binding JVA Interim Payment Update

13 Nov 2023 07:00

RNS Number : 1596T
Mast Energy Developments PLC
13 November 2023
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 13 November 2023

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

MED Binding Joint Venture Agreement Interim Payment Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcement dated 23 October 2023, under the terms of the JVA, Proventure is required to make an initial interim payment of £2,000,000 (the "Interim Payment") to the Joint Venture SPV. The Interim Payment was to be received by 10 November 2023, but MED has been notified that due to administrative and international banking transfer delays, Proventure is still in the process to deliver the Interim Payment.

 

As a result, MED has extended the Interim Payment deadline, and the Interim Payment is now expected to be received between 15 and 30 November 2023. In consideration for MED granting a further extension in respect of the Interim Payment deadline, it has been agreed between both parties that Proventure will incur and pay to MED a late payment penalty. Proventure will incur a late payment penalty for every day that the Interim Payment is received late to the amount of £3,000 per day, commencing on and calculated from 11 November 2023, until the Interim Payment and the balance of investment pursuant to the JVA are paid in full on or before the completion long-stop date of 30 November 2023.

 

If the Interim Payment is however received before or on 15 November 2023, MED will waive any late payment penalties that have been incurred until that point in time. Notwithstanding the extension of the Interim Payment deadline as referred to above, the JVA completion date and the payment of the balance of the investment due of c. £3.9m is still expected by around 30 November 2023.

 

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

Pieter Krügel

Info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEEASFAFLFDFFA
Date   Source Headline
11th Feb 20257:00 amRNSRecord High January Revenues
27th Jan 20257:00 amRNSNew Website Launch
13th Jan 20257:00 amRNSRecord High Sales Price Achieved
19th Dec 20247:00 amRNSCompany Update
3rd Dec 20247:00 amRNSCompany Update
22nd Nov 20247:00 amRNSOperating & Corporate Update
14th Oct 202412:30 pmRNSHolding(s) in Company
10th Oct 202412:20 pmRNSHolding(s) in Company
8th Oct 202412:30 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSRecord High September Revenues
1st Oct 20248:00 amRNSShares Lock-in Agreement & Pyebridge Update
12th Sep 20247:00 amRNSPyebridge Revenue Updates
30th Aug 20247:00 amRNSHalf-year Report
20th Aug 20247:00 amRNSBusiness Update
13th Aug 202412:30 pmRNSTR-1 Notification
8th Aug 20244:30 pmRNSTR-1 Notification
7th Aug 20247:00 amRNSPyebridge Revenue Update re Refurbished Genset
31st Jul 20243:00 pmRNSTR-1 Notification
30th Jul 20247:00 amRNSTR1 Notification
1st Jul 20247:00 amRNSRevenue Generation & Potential Acquisition
13th Jun 20247:00 amRNSBusiness Update
5th Jun 20241:22 pmRNSHolding(s) in Company
30th May 20242:00 pmRNSResult of AGM
29th May 20249:11 amRNSHolding(s) in Company
23rd May 20243:55 pmRNSCapitalisation of Loan Update
21st May 20247:00 amRNSBusiness Update
9th May 202410:45 amRNSHolding(s) in Company
8th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSUpdate, Loan Capitalisation & Equity Issue
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
26th Apr 20247:00 amRNSBusiness Update
23rd Apr 20242:30 pmRNSHolding(s) in Company TR 1
11th Apr 20247:00 amRNSBusiness Update
7th Mar 20248:06 amRNSQ1 2024 Corporate Presentation
4th Mar 202410:45 amRNSHolding(s) in Company
28th Feb 20247:00 amRNSFunding Partner, Agreement & Proventure Terminated
20th Feb 20241:00 pmRNSTR-1: Standard form notification of major holdings
5th Feb 20241:55 pmRNSTR-1: Standard form notification of major holdings
24th Jan 20243:45 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSMED Binding JVA Progress Update
2nd Jan 20247:00 amRNSMED Binding JVA Completion Update
22nd Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Dec 20237:00 amRNSDirector Loan & PDMR Share Sale
11th Dec 20237:52 amRNSMED Binding JVA Update
11th Dec 20237:00 amRNSMED Binding JVA Completion Update
5th Dec 20234:30 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Nov 20233:31 pmRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSMED Binding JVA Interim Payment Update
26th Oct 202310:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.